1 / 15

Non Inferiority Trial

Non Inferiority Trial. event rate. 0%. 100%. superiority study. control - placebo. experiment - drug . experiment better. experiment worse. -∞. +∞. 0. ARR=EER-CER. CER. EER. 0%. 100%. event rate. superiority study. control - placebo. experiment - drug .

aelwen
Download Presentation

Non Inferiority Trial

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Non Inferiority Trial

  2. event rate 0% 100% superiority study control - placebo experiment - drug

  3. experiment better experiment worse -∞ +∞ 0 ARR=EER-CER CER EER 0% 100% event rate superiority study control - placebo experiment - drug

  4. presumption that experiment may be worse than control! But does it matter? is it clinically significant? 0% 100% non inferiority study control - drug A experiment - drug B

  5. a positive non inferiority trial result supports the statement that the experimental treatment is no worse than the standard treatment✱ ✱within a predetermined acceptable margin of equivalence

  6. margin of equivalence“how much worse than the active control you’re willing to accept” ok if not worse than X% 0% 100% non inferiority study control - drug A experiment - drug B

  7. non inferior inconclusive experiment better experiment worse +∞ -∞ X% 0 if upper CI is less than X, non inferior! 0% 100% non inferiority study control - drug A experiment - drug B

  8. the margin of equivalence is determined by • what is deemed to be a clinically significant difference, • the expected event rates, • regulatory requirements, • the known effect of the standard treatment over placebo, • severity of the disease, • toxicity, • inconvenience, or cost of the standard treatment, adherence and • the primary endpoint.

  9. Superiority Trial • type I error is falsely finding a treatment effect when there is none • type II error is failing to detect a treatment effect when truly one exists. Non inferiority Trial • the null and alternative hypotheses are reversed; • type I error is the erroneous acceptance of an inferior new treatment, • type II error is the erroneous ejection of a truly non inferior treatment

  10. non inferior inconclusive experiment better experiment worse +∞ -∞ 7% 0 0% 3.3% 100% treatment failure at day 10 control - Abx experiment - No Abx

  11. non inferior inconclusive experiment better experiment worse 1.2% 6.8% +∞ -∞ 7% 0 0% 4.1% 5.3% 100% treatment failure at day 10 control - Abx experiment - No Abx

  12. non inferior inconclusive experiment better experiment worse 13.5% 24.3% +∞ -∞ 7% 0 0% 12.9% 26.4% 100% new lesions at day 10 control - Abx experiment - No Abx

More Related